XML 26 R7.htm IDEA: XBRL DOCUMENT v3.6.0.2
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Cash Flows from Operating Activities      
Net (Loss)/Income $ (891) $ (6,436) $ 132
Adjustments to reconcile net income/(loss) to net cash provided by operating activities:      
Equity in earnings and distribution of unconsolidated affiliates 54 37 49
Depreciation and amortization 1,367 1,566 1,523
Provision for bad debts 48 64 64
Amortization of nuclear fuel 49 45 46
Amortization of financing costs and debt discount/premiums 3 (11) (12)
Adjustment to loss/(gain) on debt extinguishment 21 (75) 25
Gain (Loss) on Extinguishment of Debt (142) 75 (95)
Amortization of intangibles and out-of-market contracts 91 81 64
Amortization of unearned equity compensation 10 41 42
Net (gain)/loss on sale of assets and equity method investments (224) 14 (4)
Defined Benefit Plan, Recognized Net Gain (Loss) Due to Curtailments 0 (21) 0
Impairment losses 1,186 5,086 97
Changes in derivative instruments 23 233 (61)
Changes in deferred income taxes and liability for uncertain tax benefits (43) 1,326 (154)
Changes in Collateral Deposits Supporting Energy Risk Management Activities 365 (381) 146
Gain on sale of emissions allowances 47 0 0
Changes in nuclear decommissioning trust liability 41 (2) 19
Cash provided/(used) by changes in other working capital, net of acquisition and disposition effects:      
Accounts receivable - trade (12) 136 (2)
Inventory 134 (26) (245)
Prepayments and other current assets (39) 8 36
Accounts payable (27) (218) (12)
Accrued expenses and other current liabilities (39) (9) (26)
Other assets and liabilities (92) (149) (217)
Net Cash Provided by Operating Activities 2,072 1,309 1,510
Cash Flows from Investing Activities      
Acquisition of businesses, net of cash acquired (209) (31) (2,936)
Capital expenditures (1,244) (1,283) (909)
(Increase)/decrease in restricted cash, net (29) 8 57
(Increase)/decrease in restricted cash to support equity requirements for U.S. DOE funded projects (3) 35 (206)
Increase (Decrease) in Notes Receivables 17 18 25
Proceeds from renewable energy grants 36 82 916
Purchases of emission allowances, net of proceeds (1) 41 (16)
Investments in nuclear decommissioning trust fund securities (551) (629) (619)
Proceeds from sales of nuclear decommissioning trust fund securities 510 631 600
Proceeds from sale of assets, net 636 27 203
Investments in unconsolidated affiliates (34) (395) (103)
Other 48 11 85
Net Cash Used by Investing Activities (824) (1,485) (2,903)
Cash Flows from Financing Activities      
Payments of dividends to preferred and common stockholders (76) (201) (196)
Net receipts from settlement of acquired derivatives that include financing elements 151 196 9
Payments for treasury stock 0 (437) (39)
Payments for Repurchase of Redeemable Preferred Stock (226) 0 0
Distributions from, net of contributions to, noncontrolling interests in subsidiaries (156) 47 189
Proceeds from sale of noncontrolling interests in subsidiaries 0 600 630
Proceeds from issuance of common stock 1 1 21
Proceeds from issuance of long-term debt 5,527 1,004 4,563
Payments of debt issuance and hedging costs (89) (21) (67)
Payments for short and long-term debt (5,913) (1,599) (3,827)
Proceeds from (Payments for) Other Financing Activities (13) (22) (18)
Net Cash (Used)/Provided by Financing Activities (794) (432) 1,265
Effect of exchange rate changes on cash and cash equivalents 1 10 (10)
Net Increase/(Decrease) in Cash and Cash Equivalents 455 (598) (138)
Cash and Cash Equivalents at Beginning of Period 1,518 2,116 2,254
Cash and Cash Equivalents at End of Period $ 1,973 $ 1,518 $ 2,116